Quick fibrinogen test for trauma patients with heavy bleeding
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial checks if a fast bedside test for fibrinogen (a protein that helps blood clot) can help guide treatment for trauma patients who are actively bleeding. It may lead to better care in the emergency department.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years or older and have had a serious injury
- You are still bleeding heavily right now
- A hospital trauma team has activated a massive transfusion protocol (meaning you need many blood products quickly)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a newer, faster blood test (viscoelastic testing) can better guide treatment for bleeding after a severe injury compared to standard blood tests. If you are in the emergency room shortly after a serious trauma, this study may help doctors decide the right treatments to stop bleeding more quickly.
This trial tests a standard set of emergency blood transfusions for people with life-threatening bleeding from a serious injury. It aims to improve survival by giving blood products quickly before reaching the hospital.
This study tests whether a drug called tranexamic acid (TXA) can help control bleeding in trauma patients. It uses a special blood test (thromboelastography) to monitor how well your blood clots during treatment.
This trial tests a simpler way to give a drug called tranexamic acid to trauma patients with heavy bleeding. The drug helps blood clot and may reduce bleeding, but it is important to check if the simplified approach is as safe as the standard one.
This study is testing a special blood test called ROTEM to see how well it can predict bleeding problems in ICU patients with sepsis or severe trauma. It may help doctors give the right treatment faster.
This trial tests whether giving a personalized dose of fibrinogen, a protein that helps blood clot, after heart surgery reduces bleeding and the need for blood transfusions. It aims to improve recovery for patients who need fibrinogen after being on a heart-lung machine.
Hear when a new Trauma Coagulopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.